Wetenschappelijk Onderzoek
Publicaties
Publicaties 2022
Nationaal MS Centrum • Wetenschappelijk onderzoek
​
​
​​​​​​​​
Bharadia, T., Vandercappellen, J., Chitnis, T., Eelen, P., Bauer, B., Brichetto, G., Lloyd, A., Schmidt, H., King, M., Fitzgerald, J., Hach, T., & Hobart, J. (2022). Multiple sclerosis journal - experimental, translational and clinical, 8(2), 20552173221105642.
​
• Impaired Sequential but Preserved Motor Memory Consolidation in Multiple Sclerosis Disease.
Borragán, G., Benoit, C. E., Schul, N., Strauss, M., De Schepper, M., Roekens, V., & Peigneux, P. (2022). Neuroscience, 487, 99–106.
Multiple Sclerosis and Related Disorders
Brichetto G., Tacchino A., Leocani L., Kos D. (2022). 67,2022, 104179,
• Ouderen kunnen na een heupfractuur langer thuis blijven wonen met een uitgebreid oefenprogramma?
De Coninck L., Peeters N. (2022) Minerva duiding, Tijdschrift voor Evidence-Based Medicine, 21(4), 87 – 90.
• Brain age as a surrogate marker for cognitive performance in multiple sclerosis.
Denissen, S., Engemann, D. A., De Cock, A., Costers, L., Baijot, J., Laton, J., Penner, I. K., Grothe, M., Kirsch, M., D'hooghe, M. B., D'Haeseleer, M., Dive, D., De Mey, J., Van Schependom, J., Sima, D. M., & Nagels, G. (2022). European journal of neurology, 29(10), 3039–3049.
• Performance of Activities of daily living in people with multiple sclerosis.
Jansa, J., Ferdinand, S., Milo, M., Løyning, I. G., Huilla, T., Kallmayer, L., Ilsbroukx, S., Filló, N., Raats, J., Jakobson, J., & Kos, D. (2022). Multiple sclerosis and related disorders, 57, 103342.
Kahraman, T., Rasova, K., Jonsdottir, J., Medina, C. S., Kos, D., Coote, S., Tacchino, A., Smedal, T., Arntzen, E. C., Quinn, G., Learmonth, Y., Pedulla, L., Moumdjian, L., & Kalron, A. (2022). . Multiple sclerosis and related disorders, 62, 103799. Advance online publication.
• Aangepaste en uitgebreide ondersteunende technologie en telezorg effectief om personen met dementie langer en veiliger thuis te laten wonen?
Kos D. (2022) Minerva duiding, Tijdschrift voor Evidence-Based Medicine, 21(2), 39 – 42.
Moumdjian L, Smedal T, Arntzen EC, van der Linden ML, Learmonth Y, Pedullà L, Tacchino A, Novotna K, Kalron A, Yazgan YZ, Nedeljkovic U, Kos D, Jonsdottir J, Santoyo-Medina C, Coote S. Arch Phys Med Rehabil. 2022 Jun 26:S0003-9993(22)00478-6. doi: 10.1016/j.apmr.2022.06.001. Epub ahead of print.
Moumdjian, L., Six, J., Veldkamp, R., Geys, J., Van Der Linden, C., Goetschalckx, M., Van Nieuwenhoven, J., Bosmans, I., Leman, M., & Feys, P. (2022). Annals of the New York Academy of Sciences, 1513(1), 153–169.
Pauwels, A., Van Schependom, J., Devolder, L., Van Remoortel, A., Nagels, G., Bjerke, M., & D'hooghe, M. B. (2022). Multiple sclerosis (Houndmills, Basingstoke, England), 28(11), 1685–1696.
Sadeghi, N., Eelen, P., Nagels, G., Cuvelier, C., Van Gils, K., D'hooghe, M. B., Van Schependom, J., & D'haeseleer, M. (2022). Journal of personalized medicine, 12(3), 433.
Temmerman, J., Van Der Veken, F., Engelborghs, S., Guldolf, K., Nagels, G., Smeets, D., Allemeersch, G. J., Costers, L., D'hooghe, M. B., Vanbinst, A. M., Van Schependom, J., Bjerke, M., & D'haeseleer, M. (2022). Journal of clinical medicine, 11(3), 523.
Van Laethem D, Van de Steen F, Kos D, Naeyaert M, Van Schuerbeek P, D’Haeseleer M, D’Hooghe MB, Van Schependom J, Nagels G. Trials. 2022 Dec;23(1):1-0. 10.1186/s13063-022-06697-9
• Correlates of patient-reported cognitive performance with regard to disability.
Van Laethem, D., De Cock, A., Van Schependom, J., Benedict, R., Nagels, G., & D'hooghe, M. (2022). Scientific reports, 12(1), 13489.
Veldkamp, R., Moumdjian, L., van Dun, K., Six, J., Vanbeylen, A., Kos, D., & Feys, P. (2022). Annals of the New York Academy of Sciences, 1508(1), 155–171.
​​​​​​​​​​​​
Publicaties 2021
Nationaal MS Centrum • Wetenschappelijk onderzoek
​​​​​​
• Performance of activities of daily living in people with multiple sclerosis
Jansa J, Ferdinand S, Milo M, Løyning IG, Huilla T, Kallmayer L, Ilsbroukx S, Filló N, Raats J, Jakobson J, Kos D.
Multiple Sclerosis and Related Disorders, October 20, 2021.
doi:10.1016/j.msard.2021.103342
Veldkamp, R., Moumdjian, L., van Dun, K., Six, J., Vanbeylen, A., Kos, D. and Feys, P.
Annals of the New York Academy of Sciences, October 2021.
doi: 10.1111/nyas.14702
Baijot J, Denissen S, Costers L, Gielen J, Cambron M, D'Haeseleer M, D'hooghe MB, Vanbinst AM, De Mey J, Nagels G, Van Schependom J.
Sci Rep. 2021, 11(1):7376
doi: 10.1038/s41598-021-86792-0
Veldkamp R, Kalron A, Baert I, Hämäläinen P, Tacchino A, D'hooge M, Giffroy X, Van Geel F, Raats J, Coninx K, Van Wijmeersch B, Feys P.
Multiple Sclerosis, 2021, 27(12):1924-1938.
doi: 10.1177/1352458520986960. Epub 2021 Feb 10. PMID: 33565906
• Global Peginterferon Beta-1a Tolerability Management Best Practices: A Nurse-Focused Delphi Approach
White S, Harris C, Allan M, Chieffe C, Eelen P, Röder C, Mouzawak C, Naylor ML.
Neurol Ther. 2021 Jun;10(1):251-263
doi: 10.1007/s40120-021-00238-3
Verduyn C, Bjerke M, Duerinck J, Engelborghs S, Peers K, Versijpt J, D'haeseleer M.
Neurology. 2021 Apr 13;96(15):705-715
doi: 10.1212/WNL.0000000000011750
Van Schependom J., Vidaurre D., Costers L., Sjøgård M., Sima DM, Smeets D, D'hooghe MB, D'haeseleer M., Deco G, Wens V, De Tiège X, Goldman S, Woolrich M, & Nagels G.
Neuroimage Clinical, 2021;30:102632
doi:10.1016/j.nicl.2021.102632
Van Geel F, Bielen H, Theunissen K, Moumdjian L, Van Nieuwenhoven J, Van Wijmeersch B, Meesen R, Ramari C, Feys P.
Int J Rehabil Res., 2021,44(2):118-125
doi: 10.1097/MRR.0000000000000457
• Brain dysconnectivity relates to disability and cognitive impairment in multiple sclerosis
Sjøgård M, Wens V, Van Schependom J, Costers L, D'hooghe M, D'haeseleer M, Woolrich M, Goldman S, Nagels G, De Tiège X.
Hum Brain Mapp. 2021 Feb 15;42(3):626-643.
doi: 10.1002/hbm.25247.
D’hooghe MB, Willekens B, Delvaux V, D’haeseleer M, Guillaume D, Laureys G, Nagels G, Vanderdonckt P, Van Pesch V, Popescu V.
BMC Neurol, 2021, 21, 227
doi:10.1186/s12883-021-02246-0
Noë S, Goeleven A, Brouwers H, Meurrens T, De Cock A, Kos D, Vanhaecht K.
Int J MS Care 2021, 23 (5): 223–228
doi: 10.7224/1537-2073.2020-019
• The role of hippocampal theta oscillations in working memory impairment in multiple sclerosis
Costers L, Van Schependom J, Laton J, Baijot J, Sjøgård M, Wens V, De Tiège X, Goldman S, D'Haeseleer M, D'hooghe MB, Woolrich M, Nagels G.
Hum Brain Mapp, 2021;42(5):1376-1390.
doi: 10.1002/hbm.25299. Epub 2020 Nov 28.
​
Publicaties 2022
Nationaal MS Centrum
​​​​​​​
​
• X
​
​
​​​​​​​​​​​​
Publicaties 2020
Nationaal MS Centrum • Wetenschappelijk onderzoek
​​​​​​​
Peeters N, Løyning IG, Ferdinand S, Kos D.
Int J MS Care. 2020 Nov-Dec;22(6):256-262.
doi: 10.7224/1537-2073.2019-094. Epub 2020 Oct 16.
Hostenbach S, Raeymaekers H, Van Schuerbeek P, Vanbinst AM, Cools W, De Keyser J, D'Haeseleer M.
Front Neurol. 2020, Jul 14;11:674.
doi: 10.3389/fneur.2020.00674.
Pannek J, Everaert K, Möhr S, Vance W, Van der Aa F, Kesselring J.
BMC Urol., 2020, 20(1):92.
doi: 10.1186/s12894-020-00650-1.
• Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
Devogelaere J, D'hooghe MB, Vanderhauwaert F, D'haeseleer M.
Neurol Sci. 2020, 41(8):1981-1983.
doi: 10.1007/s10072-020-04522-2.
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. (TOP: D'Hooghe MB, D’haeseleer M)
J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668.
doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31.
Tacchino A, Veldkamp R, Coninx K, Brulmans J, Palmaers S, Hämäläinen P, D'hooge M, Vanzeir E, Kalron A, Brichetto G, Feys P, Baert I.
JMIR Mhealth Uhealth. 2020 Apr 16;8(4):e15344.
doi: 10.2196/15344. PMID: 32343258; PMCID: PMC7218603.
Grothe M, Domin M, Hoffeld K, Nagels G, Lotze M.
Mult Scler Relat Disord, 2020,43:102159
doi: 10.1016/j.msard.2020.102159. Epub 2020 May 12.
Schiffmann I, Freund M, Vettorazzi E, Stellmann JP, Heyer-Borchelt S, D'Hooghe MB, Häußler V, Rahn AC, Heesen C.
Trials, 2020, 21, 1008
doi: https://doi.org/10.1186/s13063-020-04855-5
Kos D, Ferdinand S, Duportail M, Eijssen I, Schouteden S, Kerkhofs L, Jansa J, Fillo N, Matuska K, Beckerman H.
Multiple Sclerosis and Related Disorders,Volume 39, 2020, 101879, ISSN 2211-0348
doi: doi.org/10.1016/j.msard.2019.101879
D'Haeseleer M, Eelen P, Sadeghi N, D'Hooghe MB, Van Schependom J, Nagels G.
J Med Internet Res. 2020 May 20.
doi: 10.2196/18178. Epub ahead of print. PMID: 32447274.
Costers L, Van Schependom J, Laton J, Baijot J, Sjøgård M, Wens V, De Tiège X, Goldman S, D'Haeseleer M, D'hooghe MB, Woolrich M, Nagels G.
Hum Brain Mapp. 2020 Mar 17. doi: 10.1002/hbm.24955.
• Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes
Reynders T*, Devolder L*, Valles-Colomer M, Van Remoortel A, Joossens M, De Keyser J, Nagels G, D'hooghe M*, Raes J* (* joint first and last authorship)
Ann Clin Transl Neurol. 2020 Mar 12.
doi: 10.1002/acn3.51004.
Goudman L, Marinazzo D, Van de Steen F, Nagels G, De Smedt A, Huysmans E, Putman K, Buyl R, Ickmans K, Nijs J, Coppieters I, Moens M.
Brain Res. 2020 Apr 15;1733:146728.
doi: 10.1016/j.brainres.2020.146728. Epub 2020 Feb 14.
​​​​​​​​​​​​
Publicaties 2019
Nationaal MS Centrum • Wetenschappelijk onderzoek
​​​​​​​
Hostenbach S, Pauwels A, Michiels V, Raeymaekers H, Van Binst AM, Van Merhaeghen-Wieleman A, Van Schuerbeek P, De Keyser J, D'Haeseleer M.
Trials. 2019 Mar14;20(1):164. doi: 10.1186/s13063-019-3252-4. PMID: 30871594; PMCID: PMC6416892.
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators.
J Neurol Neurosurg Psychiatry. 2020 Mar 31. pii: jnnp-2019-322326. doi: 10.1136/jnnp-2019- 322326. [Epub ahead of print]
D’hooghe MB*, De Cock A*, Benedict RHB, Van Remoortel A, Eelen P, D’haeseleer M, Peeters E, De Keyser J, Nagels G. *joint first authorship
Mult Scler Relat Disord. 2019 Dec 20;39:101904. doi: 10.1016/j.msard.2019.101904. [Epub ahead of print]
Gidron Y, De Couck M, Reynders T, Marechal R, Engelborghs S, D'hooghe M
J Clin Med. 2019 Dec 20;9(1). pii: E26. doi: 10.3390/jcm9010026.
• Relation between heart rate variability and disease course in multiple sclerosis
Reynders T, Gidron Y, De Ville J, Bjerke M, Weets I, Van Remoortel A, Devolder L, D'haeseleer M, De Keyser J, Nagels G, D’hooghe M
J Clin Med. 2019 Dec 18;9(1). pii: E3. doi: 10.3390/jcm9010003.
Van Schependom J, Guldolf K, D'hooghe M, Nagels G, D'haeseleer M
Transl Neurodegener. 2019 Dec 9;8:37. doi: 10.1186/s40035-019-0178-4. eCollection 2019. Review. Erratum in: Transl Neurodegener. 2020 Jan 3;9:3.
• The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis.
Denissen S, De Cock A, Meurrens T, Vleugels L, Van Remoortel A, Gebara B, D'Haeseleer M, D'Hooghe MB, Van Schependom J, Nagels G.
J Cent Nerv Syst Dis. 2019 Nov 6;11:1179573519884041. doi: 10.1177/1179573519884041. eCollection 2019
• Altered transient brain dynamics in multiple sclerosis: Treatment or pathology?
Van Schependom J, Vidaurre D, Costers L, Sjogard M, D'Hooghe M, D'haeseleer M, Wens V, De Tiège X, Goldman S, Woolrich M, Nagels G Hum Brain Mapp 2019.
First published: 30 July 2019. https://doi.org/10.1002/hbm.24737
• Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.
International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu;
International Multiple Sclerosis Genetics Consortium. Cell. 2019 Jun 27;178(1):262. doi: 10.1016/j.cell.2019.06.016.
• The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis
Fluoxetine in Progressive Multiple Sclerosis : the FLUOX-PMS trial Cambron M, Mostert J, D'Hooghe M, Nagels G, Willekens B, Debruyne J, Algoed L, Verhagen W, Hupperts R, Heersema D, De Keyser J; FLUOX-PMS Study Group.
Mult Scler. 2019 Jun 20:1352458519843051. doi: 10.1177/1352458519843051
D'hooghe MB, De Cock A, Benedict RHB, Gielen J, Van Remoortel A, Eelen P, Van Merhaegen A, De Keyser J, D'haeseleer M, Peeters E, Nagels G Eur J Neurol. 2019 Jun 10. doi: 10.1111/ene.14012. [Epub ahead of print]
• Single MRI-based volumetric assessment in clinical practice is associated with MS-related disability
D'hooghe MB, Gielen J, Van Remoortel A, D'haeseleer M, Peeters E, Cambron M, De Keyser J, Nagels G. J Magn Reson Imaging. 2019 May;49(5):1312-1321. doi: 10.1002/jmri.26303. Epub 2018 Dec 31.
• Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS
Lavie C, Rollot F, Durand-Dubief F, Marignier R, Ionescu I, Casey R, Moreau T, Tourniaire P, Hutchinson M, D’Hooghe MB, Laplaud D-A, Clavelou P, De Sèze J, Debouverie M, Brassat D, Pelletier J, Lebrun-Frenay C, Le Page E, Castelnovo G, Berger E, Hautecoeur P, Heinzlef O, Durelli L, Clerico M, Trojano M, Patti F and Vukusic S; for the PRIMS and POPARTMUS investigators Mult Scler. 2019 Apr;25(4):591-600. doi: 10.1177/1352458518763080. Epub 2018 Mar 20.
Hostenbach S, Pauwels A, Michiels V, Raeymaekers H, Van Binst AM, Van Merhaeghen-Wieleman A, Van Schuerbeek P, De Keyser J, D'Haeseleer M. Trials. 2019 Mar 14;20(1):164. doi: 10.1186/s13063-019-3252-4.
• Do the posterior midline cortices belong to the electrophysiological default-mode network?
Sjøgård M, De Tiège X, Mary A, Peigneux P, Goldman S, Nagels G, van Schependom J, Quinn AJ, Woolrich MW, Wens V. Neuroimage. 2019 Jun 22;200:221-230. doi: 10.1016/j.neuroimage.2019.06.052. [Epub ahead of print]
​​​​​​​​​​​​
Publicaties 2018
Nationaal MS Centrum • Wetenschappelijk onderzoek
​​​​​​​
• Single MRI-Based Volumetric Assessment in Clinical Practice Is Associated With MS-Related Disability.
D'hooghe MB, Gielen J, Van Remoortel A, D'haeseleer M, Peeters E, Cambron M, De Keyser J, Nagels G. J Magn Reson Imaging. 2018, doi: 10.1002/jmri.26303.
• Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis.
Wiels WA, Du Four S, Seynaeve L, Flamez A, Tousseyn T, Thal D, D'Haeseleer M. Front Neurol. 2018;9:242. doi: 10.3389/fneur.2018.00242. eCollection 2018.
• Plasma citrulline levels are increased in patients with multiple sclerosis.
Vande Vyver M, Beelen R, De Keyser J, Nagels G, Van Binst AM, Verborgh C, D'haeseleer M. J Neurol Sci. 2018;387:174-178. doi: 10.1016/j.jns.2018.02.025. Epub 2018 Feb 16.
Laureys G, Willekens B, Vanopdenbosch L, Deryck O, Selleslag D, D'Haeseleer M, De Becker A, Dubois B, Dierickx D, Perrotta G, De Wilde V, van Pesch V, Straetmans N, Dive D, Beguin Y, Van Wijmeersch B, Theunissen K, Kerre T, Van de Velde A. Acta Neurol Belg. 2018;118(2):161-168. doi: 10.1007/s13760-018-0905-0. Epub 2018 Mar 13.
• Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management. Decallonne B, Bartholomé E, Delvaux V, D'haeseleer M, El Sankari S, Seeldrayers P, Van Wijmeersch B, Daumerie C. Acta Neurol Belg. 2018;118(2):153-159. doi: 10.1007/s13760-018-0883-2. Epub 2018 Jan 25.
Gielen J, Wiels W, Van Schependom J, Laton J, Van Hecke W, Parizel PM, D'hooghe MB, Nagels G. PLoS One. 2018;13(3):e0194388. doi: 10.1371/journal.pone.0194388.
• Het ontrafelen van de rol van darmflore bij Multiple Sclerose.
M. D'hooghe, J. Raes, J. De Keyser, A. Van Remoortel, L. Devolder, A. Pauwels. MS Link (2018). 4-5. Lees het artikel hier
Marie D'hooghe, Geert Van Gassen, Daphne Kos, Olivier Bouquiaux, Melissa Cambron, Danny Decoo, Andreas Lysandropoulos, Bart Van Wijmeersch, Barbara Willekens, Iris-Katharina Penner, Guy Nagels. Multiple Sclerosis and Related Disorders 22 (2018) 90-96.
Luijten MA, Eekhout I, D'Hooghe M, Uitdehaag BM, Mokkink LB. Mult Scler. 2018 Nov 9:1352458518808197. doi: 10.1177/1352458518808197.
• Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu; International Multiple Sclerosis Genetics Consortium. D'Hooghe M, Cell. 2018, pii: S0092-8674(18)31261-3. doi: 10.1016/j.cell.2018.09.049
Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators. Lancet Neurol. 2018, pii: S1474-4422(18)30069-3. doi: 10.1016/S1474-4422(18)30069
• Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS
Lavie C, Rollot F, Durand-Dubief F, Marignier R, Ionescu I, Casey R, Moreau T, Tourniaire P, Hutchinson M, D’Hooghe MB, Laplaud D-A, Clavelou P, De Sèze J, Debouverie M, Brassat D, Pelletier J, Lebrun-Frenay C, Le Page E, Castelnovo G, Berger E, Hautecoeur P, Heinzlef O, Durelli L, Clerico M, Trojano M, Patti F and Vukusic S; for the PRIMS and POPARTMUS investigators. Mult Scler. First Published March 2018.
​​​​​​​​​​​​
Publicaties 2017
Nationaal MS Centrum • Wetenschappelijk onderzoek
​​​​​​​
Maria Pia Amato, Tobias Derfuss, Bernard Hemmer, Roland Liblau, Xavier Montalban, Per Soelberg Sørensen and David H Miller; For the 2016 ECTRIMS Focused Workshop Group. Multiple Sclerosis Journal 1–14 DOI: 10.1177/1352458516686847
• Definition, prevalence and predictive factors of benign multiple sclerosis.
Tatjana Reyndersa, Miguel D'haeseleer, Jacques De Keyser, Guy Nagels, Marie B. D'hooghe. eNeurologicalSci 7 (2017) 37–43
​​​​​​​​​​​​
Publicaties 2016
Nationaal MS Centrum • Wetenschappelijk onderzoek
​​​​​​​
• Reliability of measuring regional callosal atrophy in neurodegenerative diseases.
Van Schependom J, Jain S, Cambron M, Vanbinst AM, De Mey J, Smeets D, Nagels G. Neuroimage Clin. 2016 Oct 15;12:825-831. PubMed PMID: 27830115; PubMed Central PMCID: PMC5094205.
​
• Self-reported levels of education and disability progression in multiple sclerosis.
D'hooghe MB, Haentjens P, Van Remoortel A, De Keyser J, Nagels G. Acta Neurol Scand. 2016 Dec;134(6):414-419. doi: 10.1111/ane.12555. PubMed PMID: 27761897.
​
• Measurements of brain atrophy in individual patients with multiple sclerosis.
Smeets D, Ribbens A, Sima DM, Cambron M, Horakova D, Jain S, Maertens A, Van Vlierberghe E, Terzopoulos V, Van Binst AM, Vaneckova M, Krasensky J, Uher T,Seidl Z, De Keyser J, Nagels G, De Mey J, Havrdova E, Van Hecke W. Reliable Brain Behav. 2016 Jul 19;6(9):e00518. PubMed PMID: 27688944; PubMed Central PMCID: PMC5036437.
​
Kuhle J, Hardmeier M, Disanto G, Gugleta K, Ecsedi M, Lienert C, Amato MP, Baum K, Buttmann M, Bayas A, Brassat D, Brochet B, Confavreux C, Edan G, Färkkilä M, Fredrikson S, Frontoni M, D'Hooghe M, Hutchinson M, De Keyser J, Kieseier BC, KÃmpfel T, Rio J, Polman C, Roullet E, Stolz C, Vass K, Wandinger KP, Kappos L; Mult Scler. 2016 Apr;22(4):533-43. doi: 10.1177/1352458515594440. PubMed PMID: 26362898.
​​
Kos D, Duportail M, Meirte J, Meeus M, D'hooghe MB, Nagels G, Willekens B,Meurrens T, Ilsbroukx S, Nijs J. Int J Rehabil Res. 2016 Sep;39(3):255-62. doi: 10.1097/MRR.178. PubMed PMID:27182847.
​
• Feasibility, Reliability and Predictive Value Of In-Ambulance Heart Rate Variability Registration.
Yperzeele L, van Hooff RJ, De Smedt A, Nagels G, Hubloue I, De Keyser J, Brouns R. PLoS One. 2016 May 4;11(5):e0154834. doi:10.1371/journal.pone.0154834. PubMed PMID: 27144492; PubMed Central PMCID: PMC4856404.
​
• Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Macdonell R, Nagels G, Laplaud DA, Pozzilli C, de Jong B, Martins da Silva A,Nicholas R, Lechner-Scott J, Gaebler JA, Agarwal S, Wang P, Yeh M, Hovenden M,Soelberg Sørensen P. Mult Scler. 2016 Jun;22(7):944-54. doi: 10.1177/1352458515606809. PubMed PMID: 26447066.
​
• Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.
Van Schependom J, Gielen J, Laton J, Nagels G. Mult Scler. 2016 Mar;22(3):389-92. doi: 10.1177/1352458515596458. PubMed PMID: 26199353.
​
Lowyck B, Luyten P, Vermote R, Verhaest Y, Vansteelandt K. Personal Disord. 2016 May 30. [Epub ahead of print] PubMed PMID: 27244268.
​
Lowyck B, Luyten P, Vanwalleghem D, Vermote R, Mayes LC, Crowley MJ. Personal Disord. 2016 Jan;7(1):72-9. doi: 10.1037/per0000144. PubMed PMID: 26461044.
​
Assessment. Bastiaens T, Claes L, Smits D, De Clercq B, De Fruyt F, Rossi G, Vanwalleghem D, Vermote R, Lowyck B, Claes S, De Hert M. 2016 Feb;23(1):42-51. doi: 10.1177/1073191115575069. PubMed PMID: 25736039.
​
• The pathophysiological role of astrocytic endothelin-1.
Hostenbach S, D'haeseleer M, Kooijman R, De Keyser J.Prog Neurobiol. 2016 Sep;144:88-102. doi: 10.1016/j.pneurobio.2016.04.009. Review. PMID:27132521
​​​​​​​​​​​​
Publicaties 2015
Nationaal MS Centrum • Wetenschappelijk onderzoek
​​​​​​​
• Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
JuryÅ„czyk M, Weinshenker B, Akman-Demir G, Asgari N, Barnes D, Boggild M, Chaudhuri A, D'hooghe MB, Evangelou N, Geraldes R, Illes Z, Jacob A, Kim HJ, Kleiter I, Levy M, Marignier R, McGuigan C, Murray K, Nakashima I, Pandit L, Paul F, Pittock S, Selmaj K, de Sèze J, Siva A, Tanasescu R, Vukusic S, Wingerchuk D, Wren D, Leite I, Palace J. J Neurol. 2016 Jan;263(1):140-9. doi: 10.1007/s00415-015-7952-8. Epub 2015 Nov 3.
Van Schependom J, Yu W, Gielen J, Laton J, De Keyser J, De Hert M, Nagels G. J Clin Psychiatry. 2015 Oct;76(10):e1292-9. doi: 10.4088/JCP.14m09367.
• Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Macdonell R, Nagels G, Laplaud DA, Pozzilli C, de Jong B, Martins da Silva A, Nicholas R, Lechner-Scott J, Gaebler JA, Agarwal S, Wang P, Yeh M, Hovenden M, Soelberg Sørensen P. Mult Scler. 2015 Oct 7. pii: 1352458515606809.
Heesen C, Kasper J, Fischer K, Köpke S, Rahn A, Backhus I, Poettgen J, Vahter L, Drulovic J, Van Nunen A, Beckmann Y, Liethmann K, Giordano A, Fulcher G, Solari A; AutoMS-group. PLoS One. 2015 Oct 2;10(10):e0138364. doi: 10.1371/journal.pone.0138364. eCollection 2015.
Kuhle J, Hardmeier M, Disanto G, Gugleta K, Ecsedi M, Lienert C, Amato MP, Baum K, Buttmann M, Bayas A, Brassat D, Brochet B, Confavreux C, Edan G, Färkkilä M, Fredrikson S, Frontoni M, D'hooghe MB, Hutchinson M, De Keyser J, Kieseier BC, Kümpfel T, Rio J, Polman C, Roullet E, Stolz C, Vass K, Wandinger KP, Kappos L.; European Long-term Follow-up Study Group in Interferon β-1b in Secondary-progressive Multiple Sclerosis. Mult Scler. 2016 Apr;22(4):533-43. doi: 10.1177/1352458515594440. Epub 2015 Sep 11. PMID: 26362898
Swinnen E, Lafosse C, Van Nieuwenhoven J, Ilsbroukx S, Beckwée D, Kerckhofs E. Prosthet Orthot Int. 2015 Aug 5. pii: 0309364615592696. PMID: 26246356
• Heart rate variability and baroreceptor sensitivity in acute stroke: a systematic review.
Yperzeele L, van Hooff RJ, Nagels G, De Smedt A, De Keyser J, Brouns R. Int J Stroke. 2015 Aug;10(6):796-800. doi: 10.1111/ijs.12573. Review. PMID: 26202709
• Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.
Van Schependom J, Gielen J, Laton J, Nagels G. Mult Scler. 2016 Mar;22(3):389-92. doi: 10.1177/1352458515596458. Epub 2015 Jul 21. PMID: 26199353
• Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?
D'Haeseleer M, Hostenbach S, Peeters I, Sankari SE, Nagels G, De Keyser J, D'hooghe MB. J Cereb Blood Flow Metab. 2015 Sep;35(9):1406-10. doi: 10.1038/jcbfm.2015.131. Epub 2015 Jun 24. Review.
Mokkink LB, Knol DL, van der Linden FH, Sonder JM, D'hooghe MB, Uitdehaag BM. Disabil Rehabil. 2015 Jul 26:1-7.
Calsius J, Courtois I, Feys P, Van Asch P, De Bie J, D'hooghe MB. Disabil Rehabil. 2015 Jul 2:1-7.
Bastiaens T, Claes L, Smits D, De Clercq B, De Fruyt F, Rossi G, Vanwalleghem D, Vermote R, Lowyck B, Claes S, De Hert M. Assessment. 2016 Feb;23(1):42-51.
• Music therapy and depression.
Van Assche E, De Backer J, Vermote R. Tijdschr Psychiatr. 2015;57(11):823-9. Dutch.
Lowyck B, Luyten P, Vanwalleghem D, Vermote R, Mayes LC, Crowley MJ. Personal Disord. 2016 Jan;7(1):72-9. doi: 10.1037/per0000144. Epub 2015 Oct 12.
• A psychoanalytically informed hospitalization-based treatment of personality disorders.
Vermote R, Luyten P, Verhaest Y, Vandeneede B, Vertommen H, Lowyck B. Int J Psychoanal. 2015 Jun;96(3):817-43. doi: 10.1111/1745-8315.12394. PMID: 26173889
​​​​​​​​​​​​